Delivery Order SPE2DB20D7066-SPE2DB26FC1PH
- Not listed
- The Defense Logistics Agency awarded a $4,881.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Solu-Cortef 100 mg Act-O-Vials, a corticosteroid medication used for acute inflammatory and allergic conditions. The contract was competitively awarded with no set-aside designation and is scheduled for completion by November 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a $1,144.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Solu-Cortef 100 mg Act-O-Vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This delivery order is unclassified as a set-aside contract and represents a child award under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,134 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of Solu-Cortef. The order is to be performed in Conshohocken, Pennsylvania from July 11-12, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order for the corticosteroid medication to support Defense Logistics Agency programs. No set-aside designation or subcontractors were indicated. The...
- The Defense Logistics Agency Troop Support Medical awarded a $266.70 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg vials of Solu-Cortef. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical supply chain...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $695.04 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 100mg vials of Solu-Cortef. Performance will take place in Conshohocken, Pennsylvania over one day from June 28 through June 29, 2023. The delivery order was issued under DLA Troop Support Medical's indefinite-delivery/indefinite-quantity pharmaceutical prime vendor contract to supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $29,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation. The delivery order is for 4562112325 units of Solu-Cortef 100mg vials to be delivered to a location in Conshohocken, Pennsylvania by September 12, 2023 in support of Defense Logistics Agency programs. No major subcontractors or set aside designations were identified. The award draws upon the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,987.29 to AmerisourceBergen Drug Corp for Hydrocortisone AC 12S, a corticosteroid medication commonly used for anti-inflammatory and immunosuppressant purposes. The contract is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and was awarded on November 5, 2025, without any set-aside designation. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Troop Support Medical awarded a $184 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250 mg vials of Solu-Cortef. Performance will take place in Conshohocken, Pennsylvania over a two day period concluding on September 1, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply the corticosteroid medication in support of DLA Troop Support Medical's mission to...
- The Defense Logistics Agency awarded a $5,162.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cortrosyn 0.25 mg vials, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $431,680 delivery order to Amerisourcebergen Drug Corporation for 4562001165 SOLU-CORTEF 100 MG ACT-O-VIALS. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under firm fixed pricing between August 30-31, 2023. The delivery order was issued against an existing DLA contract vehicle to supply pharmaceuticals in support of...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1PHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,883.58 to AmerisourceBergen Drug Corp for Solu-Cortef 100 mg Act-O-Vials, a corticosteroid medication used for acute inflammatory and allergic conditions. This competitively awarded, firm fixed-price delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves the Defense Health Agency and military healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's established relationship with the DLA Medical Supply Chain and its capacity to fulfill diverse pharmaceutical requirements through open competition demonstrates its capability to support federal healthcare procurement needs. This delivery order represents a routine transaction within the broader pharmaceutical prime vendor framework that enables flexible and comprehensive medical supply support for U.S. military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/10/25 |